Acadia Pharmaceuticals
ACAD
ACAD
214 hedge funds and large institutions have $3.47B invested in Acadia Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 79 increasing their positions, 67 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
23% less call options, than puts
Call options by funds: $43.4M | Put options by funds: $56.3M
Holders
214
Holding in Top 10
4
Calls
$43.4M
Puts
$56.3M
Top Buyers
| 1 | +$52.7M | |
| 2 | +$16M | |
| 3 | +$13.5M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$12.3M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$8.91M |
Top Sellers
| 1 | -$60.9M | |
| 2 | -$19.2M | |
| 3 | -$18M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$17.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$13.4M |